文献速递慢性肾脏病急性肾损伤肾小球疾病

孤立性双侧肾髓外浆细胞瘤致肾衰竭的临床过程

Clinical Course of a Patient With Kidney Failure Due to Isolated Bilateral Renal Extramedullary Plasmacytomas.
PubMed 文献 · Am J Kidney Dis · 2018-06-06

本文报告一名69岁男性在2009至2012年间出现慢性肾脏病4期,后因急性肾衰竭、厌食、乏力及胁腹痛接受影像学与双侧肾活检,免疫组化等检查确诊为双侧肾髓外浆细胞瘤;因双侧受累不宜手术,采用硼替佐米、环磷酰胺和地塞米松方案化疗4周期,3个月后肾功能恢复至基线。

要点

  • 双侧肾髓外浆细胞瘤罕见,需排除系统性受累。
  • 双侧肾脏受累时手术或联合治疗不可行。
  • 类似多发性骨髓瘤的化疗方案可使肾功能恢复。

核心结论

  • 双侧肾髓外浆细胞瘤导致肾衰竭时,采用类似多发性骨髓瘤的化疗方案可使肾功能恢复至基线。

研究设计与样本

  • 个案报道:一名69岁男性,2009至2012年间发生慢性肾脏病4期,后出现急性肾衰竭等表现。

主要发现

  • 蛋白电泳、免疫组化和免疫荧光均符合双侧肾髓外浆细胞瘤。
  • 接受4周期硼替佐米、环磷酰胺和地塞米松方案化疗后3个月,肾功能恢复至基线水平。

临床怎么用

  • 对孤立性肾脏浆细胞瘤需排除系统性受累。
  • 双侧肾脏受累时不宜手术,可考虑类似多发性骨髓瘤的化疗方案。

局限性

  • 治疗推荐常限于既往个案成功经验,缺乏统一治疗方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Plasmacytomas are rare immunoproliferative monoclonal plasma cell diseases of lymphoid lineage that may present in an isolated or systemic manner. Systemic involvement is much more common than occurrences isolated to a particular organ, and for this reason, it is imperative to rule out systemic involvement for osseous and nonosseous isolated neoplasms. These neoplasms present unique challenges due to their location, extent of involvement, vague presentation, and dearth of treatment protocol. We report the case of a 69-year-old man who developed chronic kidney disease stage 4 between 2009 and 2012. Precipitous kidney failure, anorexia, fatigue, and flank pain necessitated clinical follow-up that ultimately led to thorough imaging and bilateral kidney biopsy. Protein electrophoresis, immunohistochemistry, and immunofluorescence were all consistent with bilateral renal extramedullary plasmacytomas. Treatment recommendations are often limited to prior case successes; however, chemotherapy, radiation, and surgery are the mainstay of treatment. Although surgery or combined therapy provides the best results for patients, such options are unfeasible with bilateral kidney involvement. Therefore, a chemotherapy regimen, similar to that for multiple myeloma, was determined to be most reasonable. Treatment consisted of 4 cycles of a bortezomib, cyclophosphamide, and dexamethasone regimen. Three months following chemotherapy, kidney function returned to baseline levels.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Lawrence BJ, Petersen EL, Riches WG, et al. Clinical Course of a Patient With Kidney Failure Due to Isolated Bilateral Renal Extramedullary Plasmacytomas. Am J Kidney Dis. 2018. PMID: 29885924. doi:10.1053/j.ajkd.2018.03.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。